Giles Coghlan

Giles Coghlan

As a professional market analyst and commentator, Giles' goal is simple: to explain the current reason markets are moving the way they are so you that can make better trading decisions right now. His cutting-edge analysis has been featured in Reuters, Business Insider, WSJ, Financial Times Adviser, NBC, LBC Radio, CoinTelegraph, Guardian Observer, National Express, and numerous other prestigious financial outlets.

Tesla’s Time to Turn?

Since the high of 2021 Tesla’s share price has dropped over 60% as investors fled rate sensitive tech companies on expectations of tougher financial conditions ahead.  The question now is, ‘will the US manage a soft landing’ and potentially be able…

Can IBM find support from earnings?

The International Business Machines Corporation is an American multinational company operating in over 175 countries with its headquarters in New York.  It’s the seventh largest technology company by revenue. Recently Morgan Stanley downgraded the stock from an overweight rating to equal…

Is Bayer a buy?

Bayer AG shares surged higher on Tuesday this week on news that the German company forecast its peak sale of pharmaceuticals to €12 billion. Bayer forecast that its thrombosis treatment asundexian could bring in more than €5 billion. Revenue from…

All in for Alibaba?

Some investors have been cautious over investing in China’s tech stocks. However, recent comments from the party secretary of the People’s Bank of China that the tech sector’s heavy clampdown is coming to an end has given investors some confidence…